BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Cadence Selects Alan Connor as Next CEO


10/24/2012 7:03:45 AM

STAUNTON, Va., Oct. 23, 2012 /PRNewswire/ -- Cadence, Inc., a leading provider of medical device outsourcing solutions, announced today that Alan Connor has been selected as the company's next Chief Executive Officer. Connor has been serving as the President since April 2011 and will succeed Peter Harris in April 2013 following a six month transition period. Harris will continue as Chairman of the Board. Prior to joining Cadence in 2011, Connor enjoyed a distinguished career in the medical device industry. His experience includes a variety of executive management roles within large and medium-sized companies, such as MicroAire, MEDRAD, Arthur Andersen, and Westinghouse. This experience also includes a proven track record of building strong organizations and customer relationships while improving operating efficiencies.

"We have a very special team of highly motivated employees who remain focused on creating new manufacturing technologies to enable new product innovation," said Alan Connor. "I look forward to working closely with our employees, Peter and the Board through our next phase of growth."

"We're excited to have Alan lead our growing efforts for development and expansion in this dynamic market environment," said Peter Harris. "This promotion is the result of a two year succession planning process. Alan's personal efforts have been instrumental in our recent success and I look forward to his on-going leadership as we pursue our vision."

The Company also announced plans to spend up to $4 million to repurchase shares of the Company at such times and prices as deemed appropriate. Funds used to purchase shares will come from a combination of operating cash flow and existing debt facilities.

The company's unaudited results for the first nine months of 2012 include a 34% increase in revenue and 72% increase in income over prior year results. Earnings per share increased 52% over prior year to $1.76 per share. Earnings before interest, taxes, depreciation and amortization (EBITDA) were up 46% compared to 2012.


9 Months 2012

9 Months 2011

% Change

Sales (000s)

$41,268

$30,699

34%

EBITDA (000s)

$8,567

$5,890

46%

Operating Income (000s)

$5,328

$3,304

61%

Net Income (000s)

$3,039

$1,770

72%

Earnings/Share

$1.76

$1.16

52%

About Cadence, Inc.
Cadence is a premier contract manufacturing company improving patient outcomes by creating new medical technologies for minimally invasive devices. Headquartered in the Green Hills Technology Center in Staunton, Virginia, Cadence has over 200 shareholders. Cadence creates new-to-the-world manufacturing technologies to make devices the world has never seen. This is Outcome-based Manufacturing.

SOURCE Cadence, Inc.



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES